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I ntroduction and Methods: We performed an 
immunohistochemical study in four cases of myopitheliomas 
with objective to realize a profile in respect of differentiation 
grade by the monoclonal antibodies CK14, vimentin and 
alph-SMA, besides to investigate the cell proliferation by 
anti-PCNA, besides, we compare the immunoreactive with 
glandular normal tissue. Results: In the glandular normal 
tissue the myoepithelials cells had shown expression for 
alpha-SMA and CK 14, while that in the ductals cells, only 
the presence of CK 14 was verified. All the cases was verified 
positivy for CK 14 and vimentin, however, CK 14 had 
been present only in epithelioid and fusiform cells, while 
that the vimentin revealed positive also in the cytoplasm 
of the plasmocytoid cells. alpha-SMA was not detected in 
the neoplasic cells. Immunopositivity for the PCNA was 
observed in more than 75% of the cellular component of 
the analyzed tumors, independent of the cellular type. 
Conclusions: We concluded that it did not have difference 
in the proliferative activity among the cellular types presents 
in the myoepitheliomas and, still, the results of this study 
suggest that the constituent cells of this neoplasia one really 
represent cells of the mioepitelial ancestry, but in different 
stages of differentiation.
Keywords: minor salivary gland, immunohistochemical, myo-
epithelioma.
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INTRODUCTION
Myoepitheliomas are rare benign neoplasias of the 
salivary gland, more commonly found in the parotid1,2, be-
ing responsible for less than 7% of salivary gland tumors. 
It was first described in 19433,4. Such lesion shows a varied 
pattern of morphological growth, it may be solid, myxoid 
or reticular. It differs from the pleomorphic adenoma be-
cause it does not bear any ductal component5.
This tumor has varied cell morphology, being fu-
siform, plasmocytoid, epidermoid or clear cells6. Some 
studies have shown that fusiform cells have some muscular 
differentiation because they react to a-SMA and vimentin4, 
while other investigations did not show any muscular 
differentiation in the plasmocytoid cells4,7. According to 
Jaeger et al. (1997), these cells could have origins other 
than myoepithelial, and they lost or had changed their 
capacity to express muscular evidence markers.
Besides the many phenotypes myoepithelioma cells 
may have, some authors report that fusiform and clear cells 
have a higher prolipherative capacity, when compared to 
the plasmocytoid cells, and they also stated that the pro-
duction of myxoid material would be related to the low 
prolipherative activity of these tumors9.
Medical literature mentions the use of different 
markers for histogenetic-related prolipherative activity 
both in the normal salivary gland and also in the glandu-
lar benign and malignant tumors. Thus, we should use 
immunohistochemistry to analyze differentiation patterns 
and the prolipherative activity of the different cell types 
present in salivary gland myoepitheliomas.
MATERIALS AND METHODS
We selected 4 cases of small salivary gland myoepi-
theliomas from the files of the Pathology lab of the Oral 
Pathology Department of the Federal University of Rio 
Grande do Norte. Paraffin-bounded specimens were cut 
in 5mm thickness slices and hematoxylin-eosin was used 
for the cellular morphology analysis.
An immunohistochemical study by the strepta-
vidine-biotin technique was carried out using antibodies 
against vimentin, a-SMA, CK 14 and PCNA (Cell Prolifera-
tion Nuclear Antigen). Chart 1 lists the clones, antigenic 
recovery, dilution, incubation time and manufacturers of 
the antibodies used.
All the material selected was fixed in formaldehyde 
and embedded in paraffin, histological cross-sections of 
3μm were made and placed on slides adhered by 3-amino-
propyltriethoxy-silane (Sigma Chemical CO., St. Louis, MO, 
USA). The histology cross-sections were deparaffined in 
xylol, rehydrated in an alcohol sequence up to water and 
washed in two distilled water vials for 5 minutes each. En-
dogenous peroxidase was blocked by hydrogen peroxide 
20vol, flushed with water and incubated in TRIS-HCL (Tris-
Chart 1. Antibodies used.
Clone Specificity Dilution
Antigenic
recovery
Incubation 
time
LL002 CK 14* 1:20
Citrate, pH6.0, 
Steamer
60’
∝-SM-1 ∝-SMA* 1:50 Tripsine 0.1%, 
37º
120’
V9 Vimentin** 1:50 No recovery 120’
PC10 PCNA** 1:50
Citrate, pH6.0, 
Steamer
Overnight
hydroximethil-aminomethane), pH 7.4 for 10 minutes. The 
cross-sections were incubated with anti-mouse monoclonal 
antibody, diluted in a TRIS-HCL buffer solution (Chart 1), 
for incubation with the streptoavidine-Biotin complex, in a 
1:100 dilution for 30 minutes. For development purposes, 
we used a 0.03% diaminebenzidine cromogen solution, 
diluted in TRIS-HCL added to 0.6ml of 20vol hydrogen 
peroxide in a dark chamber for 3 minutes. For counter-
coloring we used Mayer Hematoxylin for 10 min, flushing 
in water after each step. To finish the process we used 
alcohol for dehydration and diaphanization in xylol for 
slide preparation with Permount.
Fragments of normal salivary gland were used as 
internal positive control and for comparative purposes.
The immunopositiviness analysis was carried out 
by two examiners at different times, in a double-blinded 
study through light microscopy, and all the Brown col-
ored cells in their cytoplasm or nucleus were considered 
positive (PCNA). Thus we investigated the presence or 
absence of markers, assigning the following scores: - (no 
marker); + (focal marker, less than 10% of cells marked) 
and ++ (diffuse marking).
RESULTS
Table 1 lists the patients’ clinical data.
Morphological Results
Tumors were well circumscribed, and we frequently 
found a fibrous connective tissue capsule surrounding the 
specimens. The four tumors presented a predominantly 
solid growth and organizational patterns. The specimens 
were made up of nests of cohesive and non-cohesive cells 
in a matrix that varied between hyaline and myxoid. Tumor 
cells showed different morphologies, frequently fusiform, 
polygonal of eosinophilic cytoplasm (epithelioid) and, 
sometimes, with hyper chromatic nucleus. No tumor had 
necrotic areas; although in one case we did find squamous 
metaplasia and calcifications.
Immunohistochemical results
The immunohistochemical marking for the analyzed 
antibodies may be seen in Figures 1 and 2. All the cases 
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had immunopositiviness for CK 14 and vimentin. How-
ever, CK 14 was present only in epithelioid and fusiform 
cells, while vimentin was also present in the cytoplasm of 
plasmocytoid cells. a-SMA was not detected in neoplastic 
cells, although it was present in the blood vessels, and 
they were used as internal positive control.
Immunopositiviness for PCNA was seen in more 
than 75% of cell components belonging to the analyzed 
tumors, regardless of cell type and the amount of stroma 
present.
Next to 2 of the 4 myoepitheliomas analyzed there 
was normal glandular tissue, predominantly made of ducts 
and mucous acini. In this tissue, the myoepithelial cells 
showed markers for a-SMA and CK 14. Immune mark-
ing for CK 14 was detected in ductal cells. Table 2 lists 
the immunoreactions for the analyzed myoepithelioma 
antibodies.
DISCUSSION
The benign myoepithelioma of salivary gland is 
a rare neoplasia of myoepithelial nature, made up of 
fusiform, epithelioid, plasmocytoid and clear cells10. For 
some authors such as Simpson et al. (1995) this neoplasia 
Table 1. Clinical data of the myoepithelioma cases studied.
Case Gender Age
Anatomic 
location
Clinical
diagnosis
Size
1 Male
39 
years
Hard palate
Adenoma 
pleomorphic
2,5 cm
2 Male
80 
years
Upper lip Lipoma 0,5 cm
3 Female
30 
years
Hard palate
Adenoma 
pleomorphic
0,5 cm
4 Male
31 
years
Hard palate
Adenoma 
pleomorphic
2,0 cm
Figure 1. CK 14 expression in epithelioid and fusiform cells in small 
salivary gland myoepitheliomas (SABC, 200x).
Figure 2. Vimentin immonomarking in small salivary gland myoepi-
thelioma (SABC, 200x).
is but a rare type of pleomorphic adenoma. However, 
according to Dardick et al. (1995), it is different from the 
pleomorphic adenoma because it bears little or no ductal 
component.
An interesting aspect about myoepitheliomas is the 
scarce information we have about its biological behavior, 
because of its low incidence rates. Some authors consider 
it to be more aggressive than pleomorphic adenomas11, 
while another investigation noticed, through PCNA expres-
sion, that there were no differences as far as prolipher-
ative activity is concerned between myoepitheliomas and 
pleomorphic adenomas9.
Table 2. Immunohistochemical findings in our cases of small salivary 
gland myoepitheliomas.
Case CK 14 ∝-SMA Vimentina PCNA
1 + - ++ ++
2 + - ++ ++
3 + - + ++
4 + - + ++
-: no mark, +: focal mark, ++ diffuse and intense mark
Ogawa et al. (1993) reported that cell kinetics is 
related to the biological behavior of many tumor types, 
and they noticed in their study that myoepitheliomas made 
up of fusiform, epithelioid and clear cells have greater 
rates of PCNA cells when compared to the plasmocytoid 
type, thus confirming the low prolipherative activity in this 
type. Such findings disagree from the ones in the present 
investigation because here the PCNA is marked in over 
75% of the tumors analyzed, regardless of cell type.
Myoepithelial cells, components of this neoplasia, 
are also part of many other salivary gland tumors. Ac-
cording to reports from Araújo et al. (1994) and Batsakis 
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and El-Naggar (1999) these cells are involved in many 
processes related to neoplastic growths, such as differ-
entiation of tumor cells, synthesis of basal membrane 
and maspin tumoral suppressor, besides also inhibiting 
invasion and angiogenesis. Capuano and Jaeger (2004) 
reported the presence of matrix constituents, such as lam-
inin, for example, that can induce morphologic changes 
in myoepitheliomas, causing a phenotype made up of 
plasmocytoid cells.
According to Jaeger et al. (1997) a reasonable pro-
portion of fusiform cells in the myoepitheliomas point 
toward muscular differentiation, reacting positively for 
a-SMA and vimentin, and these are called “myoepithelial 
like”.
Reports by Ellis and Auclair (1996) state that except 
for fusiform cells and some epithelioids, the true nature 
of myoepitheliomas plasmocytoid is still unclear. Jaeger et 
al. (1997) also reported that these cells did not show any 
evidence of muscular differentiation. Ogawa et al. (2003) 
believe that these cells are originated from luminal cells 
and not myoepithelial, also adding that plasmocytoid-cell 
tumors could be classified as adenomas or plasmocytoid 
adenocarcinomas.
Immunohistochemical markers for myoepithelial 
cells have included protein S-100, GFAP, cytokeratin and 
vimentin, and also a-SMA, which is associated to myo-
epithelial cells of the normal salivary gland7. Araújo et al. 
(1994) consider vimentin a marker of neoplastic myoepi-
thelial cell. However, studies performed by this group in 
200114, suggest that this protein does not happen solely in 
neoplastic myoepithelial cells, since it may be present also 
in other cell types originated from the intercalate duct.
According to Hornick and Futcher (2004), neoplas-
tic myoepithelial cells frequently lose the expression of 
muscular differentiation markers, when the immunoreac-
tivity to these markers is not required in order to confirm 
myoepithelial differentiation.
Thus, the low expression of muscle tissue markers 
has led the authors to consider plasmocytoid myoepithelio-
mas as true myoepitheliomas, despite the fact that Franque-
mont and Mills (1993) do not believe in the myoepithelial 
nature of this cell type, suggesting that the plasmocytoid 
subtype would not be a type of myoepithelioma.
Having so much debate in the literature as to the 
true nature of myoepithelioma cells, the present study 
analyzed the differentiation and the nature of small salivary 
gland myoepithelioma cell components, using epithelial 
cell differentiation markers such as CK 14 and of muscle 
tissue differentiation such as a-SMA and vimentin.
Cytokeratin are proteins of the intermediary fila-
ments of epithelial cells associated to the differentiation 
and organization of the cytoskeleton, and they are ex-
pressed in specific epithelial cells depending on their 
differentiation stage. According to Ogawa et al. (1999) 
and Ogawa et al. (2000), salivary gland myoepithelial cells 
Express CK 5 and 14; stressing the fact that these do not 
serve as specific markers for such cells because they are 
also expressed by basal ductal cells, where CK 18 and 19 
are also present.
CK 14 was present in myoepithelial cells (non-lumi-
nal), of fusiform, epithelioid and plasmocytoid morphology 
in the pleomorphic adenomas studied by Ogawa et al. 
(2003), and it disagrees from the findings of the present 
investigation in which CK 14 was only immunomarked in 
fusiform and epithelioid cells, and such fact also disagrees 
from the findings by Araújo et al. (2001) where CK 14 
and 19 marks were found in plasmocytoid cells and not 
in fusiform cells.
The vimentin found in all the cell types of the pres-
ent study was also present in all myoepithelioma cell types 
analyzed in the investigation by Araújo et al. (2001) and, 
occasionally, in non-luminal cells of the pleomorphic ad-
enomas studied by Ogawa et al. (2003). The latter authors 
stress the hypothesis that this protein is not an exclusive 
maker of the neoplastic myoepithelial cell, justifying that 
it is necessary for the migration of epithelial cells in both 
physiologic and pathologic processes, and vimentin is also 
present during the development after this process in some 
segments of the normal salivary gland.
The lack of a-SMA in the cases hereby studied and 
the immunoreactivity for vimentin were also detected 
by Savera et al. (1997) and Ogawa et al. (2003), respec-
tively.
With such findings, we believe that all morphologic 
types of myoepithelioma cells represent cells of the myo-
epithelial strain in different stages of evolution, disagree-
ing from the conclusions reached by Ogawa et al. (2003). 
The controversies present in the literature regarding the 
expression of muscle-tissue markers in fusiform, epithelioid 
and plasmocytoid cells may be justified by the fact that 
such cells may show different stages of differentiation, or 
they may have lost or changed their capacity of produc-
ing muscle-tissue markers. Moreover, it may be suggested 
that the low muscle-tissue differentiation seen “in vivo” in 
some cells which make up the myoepitheliomas may be 
caused by the inhibitory process mediated by the extra-
cellular matrix.
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